Medicare Enrolled

Dr. Ramesh Rengan, MD. PHD

Radiology - Diagnostic · Seattle, WA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
1570 N 115TH ST, Seattle, WA 98133
2063062804
In practice since 2006 (19 years)
NPI: 1801981428 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rengan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rengan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rengan

Dr. Ramesh Rengan is a radiology - diagnostic specialist in Seattle, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rengan performed 133 Medicare services across 79 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rengan received a total of $55,175 from 10 pharmaceutical and/or device companies across 64 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiology - diagnostic. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rengan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 133 Medicare services $55,175 industry payments

Medicare Practice Summary

Medicare Utilization ↗
133
Medicare services
Bottom 6% in WA for radiology - diagnostic
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
79
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~7 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Stereoscopic X-ray guidance for radiation therapy localization
This procedure uses stereoscopic X-ray imaging to precisely locate the target area for radiation therapy delivery.
133 $18 $66
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$55,175
Total received (2018-2024)
Avg $7,882/year across 7 years
Top 3% in WA for radiology - diagnostic
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
10
Companies
64
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$28,679 (52.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$18,752 (34.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,744 (14.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,254
2023
$7,050
2022
$15,477
2021
$11,991
2020
$7,284
2019
$7,367
2018
$2,752

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
IBA Proton Therapy, Inc.
$2,176
Ion Beam Applications S.A.
$1,078
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Siemens Medical Solutions USA, Inc.
$16,290
AstraZeneca Pharmaceuticals LP
$12,155
Ion Beam Applications S.A.
$7,686
Merck Sharp & Dohme LLC
$5,958
Novocure Inc.
$5,725
IBA Proton Therapy, Inc.
$3,546
Gilead Sciences, Inc.
$3,397
VIEWRAY TECHNOLOGIES INC
$298
Elekta, Inc.
$79
Varian Medical Systems, Inc.
$41
Top 3 companies account for 65.5% of all-time payments
Associated products mentioned in payments ›
ELEKTA MEDICAL LINEAR ACCELERATOR · IMFINZI · MRIdian · Oncology · Proteus · Proteus Proton Therapy System · Radiation Oncology · TrueBeam · Versa HD
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (52%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 3% for radiology - diagnostic in WA.

Looking for a radiology - diagnostic specialist in Seattle?
Compare radiology - diagnostics in the Seattle area by procedure volume, costs, and industry payment transparency.
Browse radiology - diagnostics nearby

Geographic Context

Radiology - diagnostics within 10 mi
112
Per 100K population
4.9
County median income
$122,148
Nearest hospital
SEATTLE CHILDREN'S HOSPITAL
6.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rengan is a mixed practice specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 3% of WA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rengan experienced with stereoscopic x-ray guidance for radiation therapy localization?
Based on Medicare claims data, Dr. Rengan performed 133 stereoscopic x-ray guidance for radiation therapy localization services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rengan receive payments from pharmaceutical companies?
Yes. Dr. Rengan received a total of $55,175 from 10 companies across 64 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rengan's costs compare to other radiology - diagnostics in Seattle?
Dr. Rengan's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rengan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →